Induction of a protective immunity against Schistosoma mansoni with ovalbumin-coupled Sm37-5 coadsorbed with granulocyte-macrophage colony stimulating factor (GM-CSF) or IL-12 on alum

This publication has 21 references indexed in Scilit:

• Interleukin‐12 acts as an adjuvant for humoral immunity through interferon‐γ‐dependent and ‐independent mechanisms
  European Journal of Immunology, 1997
• Evaluation of tolerability and antibody response after recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and a single dose of recombinant hepatitis B vaccine
  Vaccine, 1996
• Controlling schistosomiasis by vaccination: A realistic option?
  Parasitology Today, 1995
• Paracrine Cytokine Adjuvants in Cancer Immunotherapy
  Annual Review of Immunology, 1995
• Interleukin‐12 profoundly up‐regulates the synthesis of antigen‐specific complement‐fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo
  European Journal of Immunology, 1995
• The Adjuvant Effect of Interleukin-12 in a Vaccine Against Leishmania major
  Science, 1994
• IL-12: Initiation Cytokine for Cell-Mediated Immunity
  Science, 1993
• Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma
  Nature, 1993
• The functional and immunological significance of some schistosome surface molecules
  Parasitology Today, 1991
• Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells.
  The Journal of Experimental Medicine, 1988